Skip to main content

Table 3 SOD and MDA comparison between healthy controls, monotherapy and poly-therapy groups

From: Malondialdehyde and superoxide dismutase levels in patients with epilepsy: a case–control study

 

Monotherapy patients (n = 27)

Polytherapy patients (n = 35)

Healthy controls group (n = 62)

ANOVA (F value)

p

MDA (nmol/ml)

 Mean ± SD

5.39 ± 1.38¥

6.16 ± 1.46¥, §

4.8 ± 0.62

17.299

< 0.001*

SOD (U/ml)

 Mean ± SD

7.86 ± 1.01¥

7.39 ± 0.64¥, §

11.98 ± 1.39

229.121

< 0.001*

  1. MDA malondialdhyde, SOD superoxide dismutase, SD standard deviation, * significant
  2. ¥Significantly (higher MDA and lower SOD) than healthy controls (Tukey Post Hoc Test)
  3. §Significantly (higher MDA and lower SOD) than monotherapy group (Tukey Post Hoc Test)